Table 1 Patient Characteristics
Number of patients | 13 |
Gender (male/female) | 6/7 |
Age at start of enrollment on clinical trial (median, range) | 13.0 years (9.1-17.3) |
RET mutation | M918T (n = 13) |
Baseline LT dose | 100 mcg/day (57–200) |
Number of patients | 13 |
Gender (male/female) | 6/7 |
Age at start of enrollment on clinical trial (median, range) | 13.0 years (9.1-17.3) |
RET mutation | M918T (n = 13) |
Baseline LT dose | 100 mcg/day (57–200) |